GURUFOCUS.COM » STOCK LIST » Financial Services » Capital Markets » CME Group Inc (NAS:CME) » Definitions » Beneish M-Score

CME Group (CME Group) Beneish M-Score : -2.26 (As of Apr. 26, 2024)


View and export this data going back to 2002. Start your Free Trial

What is CME Group Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.26 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for CME Group's Beneish M-Score or its related term are showing as below:

CME' s Beneish M-Score Range Over the Past 10 Years
Min: -2.85   Med: -2.44   Max: -2.02
Current: -2.26

During the past 13 years, the highest Beneish M-Score of CME Group was -2.02. The lowest was -2.85. And the median was -2.44.


CME Group Beneish M-Score Historical Data

The historical data trend for CME Group's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CME Group Beneish M-Score Chart

CME Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.59 -2.85 -2.71 -2.34 -2.26

CME Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.23 -2.41 -2.37 -2.26 -

Competitive Comparison of CME Group's Beneish M-Score

For the Financial Data & Stock Exchanges subindustry, CME Group's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CME Group's Beneish M-Score Distribution in the Capital Markets Industry

For the Capital Markets industry and Financial Services sector, CME Group's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where CME Group's Beneish M-Score falls into.



CME Group Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of CME Group for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9973+0.528 * 0.9982+0.404 * 1.3337+0.892 * 1.1115+0.115 * 0.958
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9455+4.679 * -0.008518-0.327 * 0.9216
=-2.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $536 Mil.
Revenue was 1439.3 + 1337.8 + 1360.2 + 1441.6 = $5,579 Mil.
Gross Profit was 1226.4 + 1132.3 + 1154.5 + 1237.1 = $4,750 Mil.
Total Current Assets was $94,890 Mil.
Total Assets was $129,706 Mil.
Property, Plant and Equipment(Net PPE) was $410 Mil.
Depreciation, Depletion and Amortization(DDA) was $353 Mil.
Selling, General, & Admin. Expense(SGA) was $144 Mil.
Total Current Liabilities was $93,417 Mil.
Long-Term Debt & Capital Lease Obligation was $3,425 Mil.
Net Income was 814.6 + 750.2 + 777.6 + 883.8 = $3,226 Mil.
Non Operating Income was 182.5 + 193.7 + 218 + 283.1 = $877 Mil.
Cash Flow from Operations was 1044.3 + 856.7 + 650.4 + 902.4 = $3,454 Mil.
Total Receivables was $483 Mil.
Revenue was 1207.8 + 1227.8 + 1237.2 + 1346.6 = $5,019 Mil.
Gross Profit was 1014.8 + 1038.2 + 1051.9 + 1161.4 = $4,266 Mil.
Total Current Assets was $139,078 Mil.
Total Assets was $174,176 Mil.
Property, Plant and Equipment(Net PPE) was $456 Mil.
Depreciation, Depletion and Amortization(DDA) was $363 Mil.
Selling, General, & Admin. Expense(SGA) was $137 Mil.
Total Current Liabilities was $137,688 Mil.
Long-Term Debt & Capital Lease Obligation was $3,422 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(535.6 / 5578.9) / (483.2 / 5019.4)
=0.096005 / 0.096266
=0.9973

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(4266.3 / 5019.4) / (4750.3 / 5578.9)
=0.849962 / 0.851476
=0.9982

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (94890.2 + 409.5) / 129706.1) / (1 - (139078.3 + 455.5) / 174175.7)
=0.265264 / 0.198891
=1.3337

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=5578.9 / 5019.4
=1.1115

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(362.6 / (362.6 + 455.5)) / (352.6 / (352.6 + 409.5))
=0.443222 / 0.462669
=0.958

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(144.4 / 5578.9) / (137.4 / 5019.4)
=0.025883 / 0.027374
=0.9455

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((3425.4 + 93416.9) / 129706.1) / ((3422.4 + 137687.5) / 174175.7)
=0.746629 / 0.810158
=0.9216

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(3226.2 - 877.3 - 3453.8) / 129706.1
=-0.008518

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

CME Group has a M-score of -2.26 suggests that the company is unlikely to be a manipulator.


CME Group Beneish M-Score Related Terms

Thank you for viewing the detailed overview of CME Group's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


CME Group (CME Group) Business Description

Address
20 South Wacker Drive, Chicago, IL, USA, 60606
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The CME was founded in 1898 and in 2002 completed its initial public offering. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival, CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX in 2018 it has also expanded into cash foreign exchange, fixed income trading, and collateral optimization.
Executives
William R Shepard director 20 S. WACKER DR, CHICAGO IL 60606
Bryan T Durkin officer: MD & COO 20 S. WACKER DRIVE, CHICAGO IL 60606
Derek Sammann officer: Managing Dir Financial Product 20 S. WACKER DRIVE, CHICAGO IL 60606
Dennis Suskind director ONE NORTH END AVENUE, WORLD FINANCIAL CENTER, NEW YORK NY 10282
Suzanne Sprague officer: Sr MD Global Head of Clearing 20 SOUTH WACKER DRIVE, 18S, CHICAGO IL 60606
Timothy Francis Mccourt officer: Sr MD Global Head Equity & FX 20 S WACKER DRIVE, CHICAGO IL 60606
Elizabeth A Cook director 20 S. WACKER DRIVE, CHICAGO IL 60606
Martin J Gepsman director 20 S. WACKER DR, CHICAGO IL 60606
Terrence A Duffy director 20 S. WACKER DR, CHICAGO IL 60606
Julie Holzrichter officer: MD Operations 20 S. WACKER DRIVE, CHICAGO IL 60606
Timothy S. Bitsberger director 20 S. WACKER DRIVE, CHICAGO IL 60606
Julie Winkler officer: Chief Commercial Officer 20 S. WACKER DR., CHICAGO IL 60606
Daniel R Glickman director 20 S. WACKER DR, CHICAGO IL 60606
Hilda Harris Piell officer: MD, Organizational Development 20 S. WACKER DRIVE, CHICAGO IL 60606
Sunil Cutinho officer: President, CME Clearing 20 S. WACKER DR., CHICAGO IL 60606